Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    THROMBOCYTOPENIA, CYCLIC
Show Display Options
Rank Status Study
1 Withdrawn Different Cycles of High-dose Dexamethasone for Initial Management of Primary Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia
Interventions: Drug: Dexamethasone (4 cycles);   Drug: Dexamethasone (1 cycle)
2 Withdrawn A Multicentre Investigation of 2 Cycles Rituximab Compared With Standard Regimen in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia
Intervention: Drug: Rituximab
3 Unknown  A Chart Review of Rituximab Plus Repeated Cycles of Dexamethasone
Condition: Idiopathic Thrombocytopenia Purpura
Intervention:
4 Completed SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy
Condition: Thrombocytopaenia
Interventions: Drug: SB497115;   Other: Placebo
5 Completed
Has Results
A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma
Conditions: Chemotherapy-Induced Thrombocytopenia;   Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma;   Cancer;   Oncology;   Thrombocytopenia
Intervention: Biological: AMG 531
6 Completed A Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or Thrombocytopenia
Condition: Leukemia, Lymphocytic, Chronic, B-Cell
Intervention: Drug: Fludarabine Phosphate (Fludara)
7 Not yet recruiting Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With Dexamethasone
Conditions: ITP;   Croticosteroid Therapy
Interventions: Drug: High dose Dexamethasone pulses;   Drug: Prednisone

Study has passed its completion date and status has not been verified in more than two years.